<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310450</url>
  </required_header>
  <id_info>
    <org_study_id>0017</org_study_id>
    <nct_id>NCT03310450</nct_id>
  </id_info>
  <brief_title>Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels</brief_title>
  <acronym>TdBTS</acronym>
  <official_title>Predictors of Cardiac Troponin Release After Tour de Borobudur 2017</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitas Negeri Semarang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Research, Technology and Higher Education, Republic of Indonesia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitas Diponegoro, Indonesia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitas Negeri Semarang</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective observational study to determine predictors that related to cardiac troponin I
      (cTnI)release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after
      Tour de Borobudur (TdB) 2017
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible Criteria:

        1. minimum sample size of 80 men, non athlete, participants of TdB

        2. Classified into two groups: 160kms cycling and 100kms cycling participation

        3. 25-55 years old

        4. voluntary participate in the research

        5. eligible in pre participatory physical examination and ECG test by doctor

        6. have no history of previous acute coronary syndrome (ACS)

      Measurments:

      Interview for determine predictors of sports particapation history, medical history, family
      medical history and Rate of Perceived Exertion Measurement and examination to determine:
      antropometry parameters, clinincal conditions (SBP, DBP, hemoglobin levels, T-cholesterol and
      HDL-C levels, intensity in cycling activities (mileage, velocity, duration, and time for
      resting), hemodynamic responses (average and maximum heart rate, Karvonen Index), and
      Hydration status

      Other outcome measurements; pre and post TdB2017 measurements of cTnI, MDA, and hs-CRP
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 11, 2017</start_date>
  <completion_date type="Anticipated">May 11, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 11, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac troponin I</measure>
    <time_frame>immediate after TdB 2017 cycling touring</time_frame>
    <description>specific protein to determine cardiac injury</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MDA</measure>
    <time_frame>immediate after TdB 2017 cycling touring</time_frame>
    <description>oxydative stress marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hs-CRP</measure>
    <time_frame>immediate after TdB 2017 cycling touring</time_frame>
    <description>inflammation marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG appearance</measure>
    <time_frame>immediate after TdB 2017 cycling touring</time_frame>
    <description>ECG appearance</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Heart Arrest</condition>
  <condition>Sport Injury</condition>
  <condition>Inflammatory Response</condition>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Group 160kms cycling</arm_group_label>
    <description>willing to participate in 160kms cycling touring of TdB 2017</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 100kms cycling</arm_group_label>
    <description>willing to participate in 100kms cycling touring of TdB 2017</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>160kms cycling</intervention_name>
    <description>main exposure is long distance cycling touring (TdB) consists of two groups; 160kms and 100kms</description>
    <arm_group_label>Group 160kms cycling</arm_group_label>
    <arm_group_label>Group 100kms cycling</arm_group_label>
    <other_name>medical history</other_name>
    <other_name>sports participation history</other_name>
    <other_name>clinical appearance</other_name>
    <other_name>lipid profile status</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        participants of Tour de Borobudur Indonesia 2017
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  minimum sample size of 80 men, non athlete, participants of TdB

          -  Classified into two groups: 160kms cycling and 100kms cycling participation

          -  25-55 years old

          -  voluntary participate in the research

          -  eligible in pre participatory physical examination and ECG test by doctor have no
             history of previous acute coronary syndrome (ACS)

        Exclusion Criteria:

          -  stop cycling before finish line due to mechanical or bicycle related errors

          -  (subjects who stop cycling due to any physical symptoms and health related problem
             included in analysis)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahalul Azam, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitas Negeri Semarang</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahalul Azam, Dr</last_name>
    <phone>+628122853982</phone>
    <email>mahalul.azam@mail.unnes.ac.id</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Udin Bahrudin</last_name>
    <phone>+6281228000876</phone>
    <email>bahrudin00@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Serrano-Ostáriz E, Terreros-Blanco JL, Legaz-Arrese A, George K, Shave R, Bocos-Terraz P, Izquierdo-Álvarez S, Bancalero JL, Echavarri JM, Quilez J, Aragonés MT, Carranza-García LE. The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand J Med Sci Sports. 2011 Apr;21(2):244-9. doi: 10.1111/j.1600-0838.2009.01042.x.</citation>
    <PMID>19919634</PMID>
  </reference>
  <reference>
    <citation>Grande G, Romppel M, Glaesmer H, Petrowski K, Herrmann-Lingen C. The type-D scale (DS14) - Norms and prevalence of type-D personality in a population-based representative sample in Germany. Pers Individ Dif [Internet]. 2010;48(8):935-9. Available from: http://dx.doi.org/10.1016/j.paid.2010.02.026</citation>
  </reference>
  <reference>
    <citation>Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: 10.1186/1479-5868-8-115. Review.</citation>
    <PMID>22018588</PMID>
  </reference>
  <reference>
    <citation>Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research; Principles and quantitative methods. New York: John Wiley and Son Inc; 1982. 1-527 p.</citation>
  </reference>
  <reference>
    <citation>Bahrudin U, Morikawa K, Takeuchi A, Kurata Y, Miake J, Mizuta E, Adachi K, Higaki K, Yamamoto Y, Shirayoshi Y, Yoshida A, Kato M, Yamamoto K, Nanba E, Morisaki H, Morisaki T, Matsuoka S, Ninomiya H, Hisatome I. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction. J Mol Biol. 2011 Nov 4;413(4):857-78. doi: 10.1016/j.jmb.2011.09.006. Epub 2011 Sep 12.</citation>
    <PMID>21939669</PMID>
  </reference>
  <reference>
    <citation>Bahrudin U, Morisaki H, Morisaki T, Ninomiya H, Higaki K, Nanba E, Igawa O, Takashima S, Mizuta E, Miake J, Yamamoto Y, Shirayoshi Y, Kitakaze M, Carrier L, Hisatome I. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol. 2008 Dec 26;384(4):896-907. doi: 10.1016/j.jmb.2008.09.070. Epub 2008 Oct 7.</citation>
    <PMID>18929575</PMID>
  </reference>
  <reference>
    <citation>Purwowiyoto SL, Aryadi A, Suryaatmadja B, Ruray D, Purwowiyoto BS, Siswanto BB. Positive correlation between ECG dispersion mapping (heartvueTM) with T2DM patients. Glob Heart [Internet]. 2014;9(1):e243. Available from: http://linkinghub.elsevier.com/retrieve/pii/S221181601402119X</citation>
  </reference>
  <reference>
    <citation>de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007 Apr;28(7):850-6. Epub 2007 Apr 2. Review.</citation>
    <PMID>17403720</PMID>
  </reference>
  <reference>
    <citation>Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, Gaze D, Collinson PO. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc. 2007 Dec;39(12):2099-106.</citation>
    <PMID>18046180</PMID>
  </reference>
  <reference>
    <citation>Morrow DA. Troponins in patients with acute coronary syndromes: biologic, diagnostic, and therapeutic implications. Cardiovasc Toxicol. 2001;1(2):105-10. Review.</citation>
    <PMID>12213981</PMID>
  </reference>
  <reference>
    <citation>Jassal DS, Moffat D, Krahn J, Ahmadie R, Fang T, Eschun G, Sharma S. Cardiac injury markers in non-elite marathon runners. Int J Sports Med. 2009 Feb;30(2):75-9. doi: 10.1055/s-0028-1104572. Epub 2009 Jan 28.</citation>
    <PMID>19177312</PMID>
  </reference>
  <reference>
    <citation>Rodondi N, Marques-Vidal P, Butler J, Sutton-Tyrrell K, Cornuz J, Satterfield S, Harris T, Bauer DC, Ferrucci L, Vittinghoff E, Newman AB; Health, Aging, and Body Composition Study. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am J Epidemiol. 2010 Mar 1;171(5):540-9. doi: 10.1093/aje/kwp428. Epub 2010 Jan 28.</citation>
    <PMID>20110287</PMID>
  </reference>
  <reference>
    <citation>Eijsvogels TMH, Hoogerwerf MD, Maessen MFH, Seeger JPH, George KP, Hopman MTE, et al. Predictors of cardiac troponin release after a marathon. J Sci Med Sport [Internet]. 2015;18(1):88-92. Available from: http://dx.doi.org/10.1016/j.jsams.2013.12.002</citation>
  </reference>
  <reference>
    <citation>Serrano-Ostáriz E, Legaz-Arrese A, Terreros-Blanco JL, López-Ramón M, Cremades-Arroyos D, Carranza-García LE, Izquierdo-Alvarez S, Bocos-Terraz P. Cardiac biomarkers and exercise duration and intensity during a cycle-touring event. Clin J Sport Med. 2009 Jul;19(4):293-9. doi: 10.1097/JSM.0b013e3181ab3c9d. Erratum in: Clin J Sport Med. 2009 Sep;19(5):442. Carranza-García, Luis Enrique [added]; Alvarez-Izquierdo, Silvia [corrected to Izquierdo-Alvarez, Silvia]; Boscos-Terraz, Pilar [corrected to Bocos-Terraz, Pilar].</citation>
    <PMID>19638823</PMID>
  </reference>
  <reference>
    <citation>Eijsvogels T, George K, Shave R, Gaze D, Levine BD, Hopman MT, Thijssen DH. Effect of prolonged walking on cardiac troponin levels. Am J Cardiol. 2010 Jan 15;105(2):267-72. doi: 10.1016/j.amjcard.2009.08.679.</citation>
    <PMID>20102930</PMID>
  </reference>
  <reference>
    <citation>Neumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagl H. Effect of the &quot;Race Across The Alps&quot; in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol. 2002 Feb 15;89(4):484-6.</citation>
    <PMID>11835940</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>troponin-I</keyword>
  <keyword>hs-CRP</keyword>
  <keyword>Malondialdehyde</keyword>
  <keyword>predictors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Athletic Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

